These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28423353)

  • 1. Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.
    Taniguchi H; Hoshino D; Moriya C; Zembutsu H; Nishiyama N; Yamamoto H; Kataoka K; Imai K
    Oncotarget; 2017 Jul; 8(29):46856-46874. PubMed ID: 28423353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRDM14, a Zinc Finger Protein, Regulates Cancer Stemness.
    Taniguchi H; Imai K
    Methods Mol Biol; 2018; 1867():3-13. PubMed ID: 30155811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity and Metastasis of Breast Cancer.
    Taniguchi H; Imai K
    Methods Mol Biol; 2019; 1974():233-243. PubMed ID: 31099008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice.
    Moriya C; Taniguchi H; Miyata K; Nishiyama N; Kataoka K; Imai K
    Carcinogenesis; 2017 Jun; 38(6):638-648. PubMed ID: 28498896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRDM14: A Potential Target for Cancer Therapy.
    Ou M; Li S; Tang L
    Curr Cancer Drug Targets; 2018; 18(10):945-956. PubMed ID: 29714146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
    Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
    Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic siRNA targeting the cancer cell stemness regulator PRDI-BF1 and RIZ domain zinc finger protein 14.
    Imai K; Taniguchi H
    Proc Jpn Acad Ser B Phys Biol Sci; 2022; 98(7):325-335. PubMed ID: 35908955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
    Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene amplification and overexpression of PRDM14 in breast cancers.
    Nishikawa N; Toyota M; Suzuki H; Honma T; Fujikane T; Ohmura T; Nishidate T; Ohe-Toyota M; Maruyama R; Sonoda T; Sasaki Y; Urano T; Imai K; Hirata K; Tokino T
    Cancer Res; 2007 Oct; 67(20):9649-57. PubMed ID: 17942894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
    Rodríguez M; Silva J; Herrera A; Herrera M; Peña C; Martín P; Gil-Calderón B; Larriba MJ; Coronado MJ; Soldevilla B; Turrión VS; Provencio M; Sánchez A; Bonilla F; García-Barberán V
    Oncotarget; 2015 Dec; 6(38):40575-87. PubMed ID: 26528758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
    Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
    Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10.
    Gong C; Qu S; Lv XB; Liu B; Tan W; Nie Y; Su F; Liu Q; Yao H; Song E
    Nat Commun; 2014 Nov; 5():5406. PubMed ID: 25406648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14-specific chimeric siRNA/nanocarrier complex.
    Taniguchi H; Natori Y; Miyagi Y; Hayashi K; Nagamura F; Kataoka K; Imai K
    Int J Cancer; 2021 Aug; 149(3):646-656. PubMed ID: 33783816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.
    Tracey LJ; Brooke-Bisschop T; Jansen PWTC; Campos EI; Vermeulen M; Justice MJ
    Mol Cancer Res; 2019 Jul; 17(7):1468-1479. PubMed ID: 31015254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
    Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
    Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
    Liu R; Li J; Lai Y; Liao Y; Liu R; Qiu W
    Int J Biol Macromol; 2015 Nov; 81():491-7. PubMed ID: 26275461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Kar S; Patra SK
    Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
    Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
    Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity.
    Messier TL; Boyd JR; Gordon JA; Stein JL; Lian JB; Stein GS
    J Cell Physiol; 2016 Nov; 231(11):2474-81. PubMed ID: 26916849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.